Clario's ECG solution for Phase I through IV clinical trials is a comprehensive service designed to address cardiac safety concerns in drug development. The solution offers centralized ECG collection, which is crucial for optimal enrollment decisions, increased patient safety, and faster trial progression. With 50 years of experience, Clario provides customizable options for both traditional site-based ECG collection and home ECG monitoring, ensuring high-quality data and consistent analysis across various trial designs. The ECG solution supports both conventional and decentralized clinical trials, featuring user-friendly designs that enable patient-administered ECGs at home. This flexibility allows sponsors to adapt to changing trial requirements and environments. Clario's approach aims to minimize the risks associated with cardiac safety issues, which are among the leading causes of delays or abandonment in promising drug development.

Key Features

Centralized ECG Collection Clario's solution provides centralized ECG data collection and analysis, ensuring consistency and quality across trial sites.

• Standardized assessments and high-quality data collection
• Centralized monitoring to minimize risk

Flexible ECG Collection Models The solution offers both traditional and home ECG collection options to suit various trial designs.

• Traditional ECG collection with consistent equipment and methodology
• Home ECG collection with simple, easy-to-use design for patient-administered tests

Integrated Platform Clario's ECG solution is fully integrated with their platform, enabling seamless data management.

• Clinical-trial-quality centralized ECG reads
• Support for both patient and traveling nurse collection models

Benefits

Improved Data Quality Clario's solution ensures high-quality, consistent ECG data throughout the trial.

• Reduces errors in patient inclusion/exclusion due to inaccurate measurements
• Provides clean, digital ECG data delivered centrally to the client

Enhanced Trial Flexibility The solution adapts to various trial designs and changing regulatory requirements.

• Supports both site-based and decentralized clinical trials
• Enables sponsors to execute trials in challenging and evolving environments

Reduced Risk and Accelerated Trials By addressing cardiac safety concerns effectively, the solution helps minimize delays in drug development.

• Drives optimal enrollment decisions
• Increases patient safety throughout the trial